SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-497012"
 

Search: id:"swepub:oai:DiVA.org:uu-497012" > Amyloid nomenclatur...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Buxbaum, Joel N.Scripps Res Inst, Dept Mol Med, Protego Biopharm San Diego, La Jolla, CA USA. (author)

Amyloid nomenclature 2022 : update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2022-11-24
  • Taylor & Francis Group,2022
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-497012
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-497012URI
  • https://doi.org/10.1080/13506129.2022.2147636DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The Nomenclature Committee of the International Society of Amyloidosis met at the XVIII International Symposium on Amyloidosis in September and virtually in October 2022 with discussions resulting in this upgraded nomenclature recommendation. The nomenclature principles remain unchanged but there is an ongoing discussion regarding the importance and varying nature of intracellular protein aggregates, particularly those associated with neurodegenerative diseases. Six novel proteins were added to the list of human amyloid fibril proteins. Of these, three are polypeptide hormones and two currently utilised peptide drugs, making the number of known iatrogenic amyloid forms four, all appearing as subcutaneous nodules at the injection site. The sixth novel amyloid fibril protein is the transmembrane 106B protein, forming intracellular amyloid fibrils in disorders associated with frontotemporal dementia. The number of known human amyloid fibril proteins is now 42.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Dispenzieri, AngelaMayo Clin, Div Hematol, Rochester, MN USA. (author)
  • Eisenberg, David S.Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA USA. (author)
  • Fändrich, MarcusUlm Univ, Inst Prot Biochem, Ulm, Germany. (author)
  • Merlini, GiampaoloFdn IRCCS Policlin San Matteo, Amyloid Res & Treatment Ctr, Pavia, Italy.;Univ Pavia, Pavia, Italy. (author)
  • Saraiva, Maria J. M.Univ Porto, Inst Mol & Cellular Biol, Mol Neurobiol, Porto, Portugal. (author)
  • Sekijima, YoshikiShinshu Univ, Dept Med Neurol & Rheumatol, Sch Med, Matsumoto, Japan. (author)
  • Westermark, PerUppsala universitet,Neuroonkologi och neurodegeneration(Swepub:uu)perweste (author)
  • Scripps Res Inst, Dept Mol Med, Protego Biopharm San Diego, La Jolla, CA USA.Mayo Clin, Div Hematol, Rochester, MN USA. (creator_code:org_t)

Related titles

  • In:Amyloid: Taylor & Francis Group29:4, s. 213-2191350-61291744-2818

Internet link

Find in a library

  • Amyloid (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view